Global Glaucoma Surgery Devices Market Report

The global demand for Glaucoma Surgery Devices Market is presumed to reach the market size of nearly USD 3.43 Billion by 2032 from USD 2.16 Billion in 2023 with a CAGR of 5.26% under the study period 2024-2032.

Glaucoma surgery devices are medical instruments and equipment developed for treating glaucoma, a chronic ocular disorder characterized by increased intraocular pressure that may affect and even damage the optic nerve, potentially leading to vision loss. These instruments are used in various surgical operations where intraocular pressure is reduced by enhancing the outflow or reducing the production. These include filtration implants, drainage devices, micro-invasive glaucoma surgery, and laser systems. Each type has a specific purpose; for instance, filtration implants create a new drainage pathway, while the MIGS systems are minimally invasive options that reduce some of the major surgical risks and decrease recovery times. These advances have brought innovations such as smart implants, which can offer real-time pressure monitoring, greatly improving treatment efficacy and patient outcomes.

Market Dynamics

The increase in glaucoma prevalence, technological advancement, and the geriatric population drive the market growth of glaucoma surgery devices. The American Academy of Ophthalmology estimated that the number of people affected with glaucoma will increase to 79.6 million globally by 2040, creating a huge demand for effective surgeries. Technological innovation is a significant market driver. Technological innovations such as micro-invasive glaucoma surgery (MIGS) devices offer less invasive options that reduce patient recovery times and surgical risks. For instance, Glaukos Corporation, with its iStent inject, has revolutionized the field by its capability to lower intraocular pressure with a tiny, ab interno stent, which increases comfort & outcomes for the patients.

Moreover, the strategic moves of major players in the market, such as acquisitions and collaborations, further propel market growth. Companies like Alcon and Johnson & Johnson Vision have diversified their products through strategic mergers and the establishment of new technologies. Alcon's acquisition of the surgical device company Ivantis is among the consolidations that have been able to allow firms to improve their technological capability and extend market reach. The market is an opportunistic one as it continues to evolve into emerging regions that boast rapid development of healthcare infrastructure and increased awareness related to the treatment options for glaucoma. This evolution presents significant opportunities for market growth.  However, high costs and limited reimbursement policies are likely to restrain the growth of the market, making treatments less accessible and unaffordable for patients.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Glaucoma Surgery Devices. The growth and trends of Glaucoma Surgery Devices industry provide a holistic approach to this study.

Market Segmentation

This section of the Glaucoma Surgery Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Glaucoma Drainage Device (Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents)
• Traditional Surgery Devices (Scalpel, Forceps, Ophthalmic Scissors, Punch, Sutures, Surgical Drapes, Microcatheter, Others)
• Diamond Knives
• Laser Systems
• Others

By Surgery Method

• Traditional Glaucoma Surgery (Trabeculectomy, Tube Shunt Surgery)
• Minimal Invasive Glaucoma Surgery (Trabecular Meshwork Bypass, Suprachoroidal Space Implants, Subconjunctival Space Implants, Schlemm’s Canal Implants, Gonioscopy-assisted Transluminal Trabeculectomy, Endocyclophotocoagulation)
• Laser Surgery (Trabeculoplasty, Iridotomy, Cyclophotocoagulation)

By End-use

• Hospitals
• Ophthalmic Clinics
• Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Glaucoma Surgery Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Glaucoma Surgery Devices Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Glaucoma Surgery Devices market include Alcon Inc., Glaukos Corp., Johnson & Johnson Vision, AbbVie Inc. (Allergan Plc.), ASICO LLC, Carl Zeiss Meditec AG, Katalyst Surgical, Lumenis Ltd., Ziemer Ophthalmic Systems AG, Iridex Corp., Altomed. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.